Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Feb 6, 2026

IQVIA forecasts weak annual profit on higher interest expenses

Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong fourth-quarter results underscored improving demand from pharmaceutical clients.

Reuters • Feb 5, 2026

IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y

IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.

Zacks Investment Research • Feb 5, 2026

IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 5, 2026

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended December 31, 2025. "IQVIA closed 2025 with strong performance across all segments," said Ari Bousbib, chairman and CEO of IQVIA. "We delivered near double digit revenue and EPS growth, and the strongest.

Business Wire • Feb 5, 2026

IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $3.42 per share, beating the Zacks Consensus Estimate of $3.4 per share. This compares to earnings of $3.12 per share a year ago.

Zacks Investment Research • Feb 5, 2026

IQV or IDXX: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Feb 4, 2026

IQVIA Set to Report Q4 Earnings: Here's What You Should Know

IQV is set to report fourth-quarter 2025 earnings results on Feb. 5, with revenues expected to rally 7.2% y/y to $4.2B and EPS to rise 9% on segment growth.

Zacks Investment Research • Feb 3, 2026

Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Zacks Investment Research • Feb 3, 2026

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic long-term collaboration with Boehringer Ingelheim. Boehringer Ingelheim has selected IQVIA's Data-as-a-Service (DaaS+) technology offering as the accelerator to power its global commercial data harmonization and transformation journey. This collaboratio.

Business Wire • Jan 29, 2026